Elevated levels of IL-1β in the peripheral blood and tumor tissues have been linked to poorer survival rates in NSCLC, indicating the importance of further exploration into the prognostic implications of IL-1β [20,21,22]. This evidence concerns the gene IL1B and non-small cell lung carcinoma.